Controlling the pandemic during the SARS-CoV-2 vaccination rollout

João Viana; Christiaan H. van Dorp; Ana Nunes; Manuel C. Gomes; Michiel van Boven; Mirjam E. Kretzschmar; Marc Veldhoen; Ganna Rozhnova

doi:10.1038/s41467-021-23938-8

Nature Communications (Jun 2021)

Controlling the pandemic during the SARS-CoV-2 vaccination rollout

João Viana,
Christiaan H. van Dorp,
Ana Nunes,
Manuel C. Gomes,
Michiel van Boven,
Mirjam E. Kretzschmar,
Marc Veldhoen,
Ganna Rozhnova

Affiliations

João Viana: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University
Christiaan H. van Dorp: Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory
Ana Nunes: Faculdade de Ciências, Universidade de Lisboa
Manuel C. Gomes: Faculdade de Ciências, Universidade de Lisboa
Michiel van Boven: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University
Mirjam E. Kretzschmar: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University
Marc Veldhoen: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
Ganna Rozhnova: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University

DOI: https://doi.org/10.1038/s41467-021-23938-8
Journal volume & issue: Vol. 12, no. 1
pp. 1 – 15

Abstract

Read online

Despite the consensus that mass vaccination against SARS-CoV-2 will ultimately end the pandemic, it is not clear when and which control measures can be relaxed during the rollout of vaccination programmes. Here, the authors investigate relaxation scenarios using an age-structured transmission model that has been fitted to data for Portugal.

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal